With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As more countries rise out of poverty, CGD’s work in this area focuses on the inequities and emerging problems that jeopardize global health progress.
As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally and equitably? How can the world advance global health security and fight infectious diseases? What can be done to address treatment inequalities between developed and developing countries? What are the benefits of, mechanisms for, and threats to, greater family planning provision? CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.
On International Women’s Day it is right to celebrate the huge advances in women’s rights during our own lifetimes. In almost every country in the world, women are closer to achieving equality in economic and social activity. However, even as we celebrate progress, we cannot lose sight of the road still to travel.
Aid allocation has been a topic of much investigation across several fields. In particular, many studies have looked at the patterns of development assistance for health (DAH). For example, a study by Hanlon and colleagues found that regional variations in DAH country allocations were only in part explained by differences in disease burden or income levels. If DAH allocation is not primarily driven by the health and financial needs of those receiving it, then on what grounds is it allocated?
In collaboration with the Salud Mesoamerica Initiative (SMI), CGD is pleased to invite you to a two-day conference highlighting lessons learned from SMI and how SMI’s experience can inform other programs in the future of healthcare. CGD has worked on results-based financing for years. From analyzing performance-based incentives to exploring cash on delivery aid to improving value for money for the Global Fund and its partners, we have been examining ways to maximize the impact of funding on health outcomes. We now have rigorous evaluations and evidence from SMI, a large-scale results-based funding program. This model public-private partnership allocates funding at the national level based on measurable improvements in coverage and quality of reproductive, maternal, newborn, and child healthcare. It has brought together international donors, a development bank, regional bodies, national governments, and local stakeholders in an innovative partnership that rewards for health system strengthening and increased equity.
Today, politicians are under growing pressure to squeeze more out of every dollar and guarantee greater access to better, more affordable healthcare for their citizens. In such a resource-constrained environment, wasting trillions of dollars on health every year is not viable. This note provides an overview of some of the approaches and policy options that the National Health Service in England has been using to maximise value for money.
When RCTs are not an option, geospatial data can be a powerful tool for evaluating development projects – opening up opportunities to understand what works, what doesn’t, and why - at a substantially lower time and cost. Dr. Ariel BenYishay will provide an overview of the growing field of geospatial impact evaluation highlighting how the increasing availability of geo-referenced intervention and outcome data offers many new opportunities for research and evaluation across the development field that can be just as (if not more) effective as randomized control trials (RCTs). Dr. BenYishay will share a recent case study using geospatial data that measured the impacts of Chinese development activities on sensitive forests in Tanzania and Cambodia between 2000 and 2014 that shows how powerful this tool can be.
Last month, CGD hosted four former directors of USAID’s Office of Population and Reproductive Health to reflect on their experiences, which spanned US administrations from Ronald Reagan to Barack Obama. (You can watch the event here). Below, we highlight three main takeaways— the critical role of technical leadership, the importance of data, and the need to start with the end in mind when planning for successful transitions.
In 2013, a CGD working group signaled important benefits of development impact bonds, and worked through some of the “how-to” of design and implementation. Yet five years later, only three development impact bonds have launched. Why is this the case? Why is it so hard to get DIBs off the ground? What can we learn from the structuring and financing of DIBs to date to ease the way for future efforts?